Chan Siu-Lun

The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.

H. K. Ng, D. Girling, D. Ellard, 1986, The American review of respiratory disease.